1-(Methylsulfonyl)spiro[indoline-3,4'-piperidine]hydrochloride
95%
- Product Code: 74936
CAS:
159634-86-3
| Molecular Weight: | 302.82 g./mol | Molecular Formula: | C₁₃H₁₉ClN₂O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09033869 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry, ventilated |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly as a key intermediate in the synthesis of biologically active molecules. Its spirocyclic structure makes it valuable for creating compounds with potential therapeutic effects, especially in the field of central nervous system (CNS) disorders. It has been explored for its role in modulating specific receptors or enzymes involved in neurological pathways, potentially contributing to the development of treatments for conditions like depression, anxiety, or neurodegenerative diseases. Additionally, its unique chemical framework is leveraged in medicinal chemistry to optimize drug-like properties, such as bioavailability and stability, in early-stage drug discovery programs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.500 | 10-20 days | ฿56,286.00 |
+
-
|
| 1.000 | 10-20 days | ฿69,831.00 |
+
-
|
1-(Methylsulfonyl)spiro[indoline-3,4'-piperidine]hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly as a key intermediate in the synthesis of biologically active molecules. Its spirocyclic structure makes it valuable for creating compounds with potential therapeutic effects, especially in the field of central nervous system (CNS) disorders. It has been explored for its role in modulating specific receptors or enzymes involved in neurological pathways, potentially contributing to the development of treatments for conditions like depression, anxiety, or neurodegenerative diseases. Additionally, its unique chemical framework is leveraged in medicinal chemistry to optimize drug-like properties, such as bioavailability and stability, in early-stage drug discovery programs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :